Skip to search formSkip to main contentSkip to account menu

Pneumovax 23

Known as: PPSV23 
National Institutes of Health

Related topics

Related topics

13 relations

Broader (13)

23-valent pneumococcal capsular polysaccharide vaccinePolyvalent pneumococcal vaccinepneumococcal capsular polysaccharide type 10A vaccinepneumococcal capsular polysaccharide type 11A vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Pneumococcal Vaccination Among Lupus Patients
Purpose Pneumococcal vaccination (PV) is indicated for the elderly (age ≥65 years) and those with chronic disease or who are… 
2019
2019
Altered immunogenicity of 23-valent pneumococcal polysaccharide vaccine in elderly patients with diabetes who revealed lower responses to concomitant administration of BIKEN varicella zoster vaccine…
2018
2018
Immunogenicity of sequential 13-valent conjugated and 23-valent unconjugated pneumococcal vaccines in a population of children with lupus
Pneumococcal vaccination is recommended as a quality indicator for management of children with systemic lupus erythematosus… 
Review
2015
Review
2015
Recent Developments and Future Directions of Pneumococcal Vaccine Recommendations.
Review
2015
Review
2015
Adverse Reactions to Pneumococcal Vaccine in Pediatric and Adolescent Patients with Sickle Cell Disease
To review five cases of severe adverse reactions after vaccination with the 23‐valent pneumococcal polysaccharide vaccine (PPSV23… 
Highly Cited
2014
Highly Cited
2014
Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine.
Review
2013
Review
2013
Pneumococcal vaccination of older adults
Pneumococcal polysaccharide vaccines have demonstrated effectiveness in prevention of invasive pneumococcal disease (IPD).1… 
2011
2011
Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.
PURPOSE The purpose of this study was to determine whether active immunization against pneumolysin (PLY), or polysaccharide… 
Highly Cited
2009
Highly Cited
2009
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.
RATIONALE Debate exists about the immunogenicity and protective efficacy of antibodies produced by the 23-valent pneumococcal… 
2009
2009
Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
Abstract Pneumococcal disease, which includes pneumococcal pneumonia, meningitis, and bacteremia, is associated with substantial… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)